News Shoe Insoles Meant to Make Walking Easier for MS Patients to Be Tested in Australia Shoe Insoles Meant to Make Walking Easier for MS Patients to Be Tested in Australia by Patricia Silva, PhD | February 9, 2017 Share this article: Share article via email Copy article link A specialty shoe insole that mayĀ helpĀ multiple sclerosis (MS) patients walk and go about their daily lives with more assurance and ease was developedĀ by an Australian-led research team, which is now seeking 176 patientsĀ to test the insoleĀ in a three-month trial. The study is led by Anna Hatton, a physiotherapy professor at the University of Queensland’sĀ School of Health and Rehabilitation SciencesĀ in Australia, andĀ is supported byĀ Multiple Sclerosis Research Australia. āMany people with MS experience problems with walking which can make day-to-day activities difficult and often leads to falls, so improving walking ability is of primary importance in maintaining health, independence, and quality of life,ā Hatton said in a press release. āEvidence suggests that wearing textured shoe insoles, which are designed to stimulate receptors on the soles of the feet, may be one possible option to help improve gait,ā she added. āWe now need people with MS to help us investigate whether the novel insoles influence the way the leg and trunk muscles work while walking on both even and uneven surfaces.ā The team will also investigate changes in the perception of sensations in the feet and awareness of the foot’s position, as these play a key role in keeping the body balanced when walking. āWe know from previous studies that people with MS often have poor sensation on the soles of their feet,ā Hatton said. āTherefore, wearing a specially designed shoe insole, which enhances sensory information at the feet, could help people affected by MS to walk better.ā Researchers hopeĀ that this study will result in a relativelyĀ inexpensive and easy-to-use treatment approachĀ that might giveĀ MS patients aĀ more autonomous lifestyle. Study participants must be older than 18, diagnosed withĀ MS, be able to walk 100 meters (about 110 yards)Ā independentlyĀ or with only minor assistance from a mobility aid, and have no other neurological disorders or cognitive impairment. Team members includes Sandra Brauer and Katrina Williams of Queensland University, Keith Rome with the Auckland University of Technology in New Zealand, and John Dixon of Teesside University in the U.K. The study willĀ take place at Queens University’s Gait Lab. Interested MS patientsĀ can contact Hatton at [email protected], or by calling +61-7-3365-4590 or +61-7-3365-3299. Print This Page About the Author Patricia Silva, PhD PatrĆcia holds a PhD in medical microbiology and infectious diseases from the Leiden University Medical Center, Netherlands, and completed a postdoctoral research fellowship at the Instituto de Medicina Molecular, Lisbon, Portugal. Her work in academia was mainly focused on molecular biology and the genetic traits of infectious agents such as viruses and parasites. PatrĆcia earned several travel awards to present her work at international scientific meetings. She is a published author of several peer-reviewed science articles. Tags Australia, balance, clinical trial, mobility
April 22, 2024 News by Marisa Wexler, MS AAN 2024: Briumvi found to ease disability in certain MS patients
April 22, 2024 Columns by Desiree Lama Learning to manage cognitive impairment with multiple sclerosis
April 19, 2024 News by Lindsey Shapiro, PhD AAN 2024: Earlier Ocrevus lowers MS progression risk over 10 years